[go: up one dir, main page]

MX2015007130A - Formulaciones de triazina con un segundo principio activo y tensioactivo(s). - Google Patents

Formulaciones de triazina con un segundo principio activo y tensioactivo(s).

Info

Publication number
MX2015007130A
MX2015007130A MX2015007130A MX2015007130A MX2015007130A MX 2015007130 A MX2015007130 A MX 2015007130A MX 2015007130 A MX2015007130 A MX 2015007130A MX 2015007130 A MX2015007130 A MX 2015007130A MX 2015007130 A MX2015007130 A MX 2015007130A
Authority
MX
Mexico
Prior art keywords
active ingredient
triazine
surfactant
formulations
relates
Prior art date
Application number
MX2015007130A
Other languages
English (en)
Other versions
MX374912B (es
Inventor
Anne Claire Le Meur
Florence Guimberteau
Original Assignee
Ceva Sante Animale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47471627&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2015007130(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ceva Sante Animale filed Critical Ceva Sante Animale
Publication of MX2015007130A publication Critical patent/MX2015007130A/es
Publication of MX374912B publication Critical patent/MX374912B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D99/00—Subject matter not provided for in other groups of this subclass
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2093—Containers having several compartments for products to be mixed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Paints Or Removers (AREA)

Abstract

La presente invención se refiere a nuevas composiciones que comprenden al menos un principio activo de la familia de las triazinas combinado con otro principio activo y compuestos específicos que permiten la reducción de la formación de espuma. Más particularmente, la invención se refiere a composiciones en forma de suspensiones acuosas que comprenden una triazina, un complejo de hierro y uno o más tensioactivos que tienen un HLB concreto.
MX2015007130A 2012-12-07 2013-12-06 Formulaciones de triazina con un segundo principio activo y tensioactivo(s). MX374912B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12306548.4A EP2740492A1 (en) 2012-12-07 2012-12-07 Triazine formulations with a second active ingredient and surfactant(s)
PCT/EP2013/075760 WO2014086960A1 (en) 2012-12-07 2013-12-06 Triazine formulations with a second active ingredient and surfactant(s)

Publications (2)

Publication Number Publication Date
MX2015007130A true MX2015007130A (es) 2015-10-20
MX374912B MX374912B (es) 2025-03-06

Family

ID=47471627

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015007130A MX374912B (es) 2012-12-07 2013-12-06 Formulaciones de triazina con un segundo principio activo y tensioactivo(s).

Country Status (22)

Country Link
US (4) US11331321B2 (es)
EP (3) EP2740492A1 (es)
JP (2) JP6363092B2 (es)
KR (1) KR102242359B1 (es)
CN (3) CN110201175A (es)
AU (1) AU2013353984B2 (es)
BR (1) BR112015013179B1 (es)
CA (1) CA2892888C (es)
CL (1) CL2015001565A1 (es)
DK (1) DK4082524T3 (es)
ES (1) ES3030283T3 (es)
FI (1) FI4082524T3 (es)
HR (2) HRP20250623T1 (es)
HU (2) HUE071706T2 (es)
MX (1) MX374912B (es)
PH (1) PH12015501219B1 (es)
PL (1) PL4082524T3 (es)
PT (2) PT4082524T (es)
RU (1) RU2652136C2 (es)
SI (2) SI4082524T1 (es)
UA (1) UA115460C2 (es)
WO (1) WO2014086960A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2740492A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Triazine formulations with a second active ingredient and surfactant(s)
EP2740469A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale New treatments with triazines
EP3473268A1 (en) * 2017-10-20 2019-04-24 IDT Biologika GmbH Combined preparation for parenteral use
WO2019219855A1 (en) * 2018-05-16 2019-11-21 Ceva Sante Animale Veterinary compositions and the uses thereof for controlling iron deficiencies in non-human mammals
EP3578181A1 (en) 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulation for use in the simultaneous treatment of coccidial infections and iron deficiencies
EP3578182A1 (en) 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulations containing triazinones and iron with a low amount of free iron ions
DE102018220624A1 (de) 2018-11-29 2020-06-04 B. Braun Melsungen Ag Wässrige Zusammensetzung, insbesondere zur Behandlung von Schleimhaut und/oder Wunden
KR102799769B1 (ko) * 2019-04-12 2025-04-25 현대자동차주식회사 사이드링크 통신을 수행하는 방법 및 그 장치

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3145142A (en) * 1962-05-31 1964-08-18 Du Pont Anticonvulsant process and composition
DE2718799A1 (de) 1977-04-27 1978-11-09 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer
US4493826A (en) * 1982-01-25 1985-01-15 Schering Corporation Gentamicin-gleptoferron compositions
US5219853A (en) 1983-01-12 1993-06-15 Bayer Aktiengesellschaft Agent for coccidiosis
DE3300793A1 (de) 1983-01-12 1984-07-12 Bayer Ag, 5090 Leverkusen Coccidiosemittel
DE3516632A1 (de) 1985-05-09 1986-11-13 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 1,3,5-triazintrionen
DE19603954C2 (de) 1996-02-05 2003-04-17 Wagon Automotive Gmbh Prallträger für ein Kraftfahrzeug
DE19603984A1 (de) 1996-02-05 1997-08-07 Bayer Ag Granulate von Triazinen
US6470017B1 (en) 1998-04-21 2002-10-22 Nippon Telegraph And Telephone Corporation Packet multiplexing apparatus
DE19824483A1 (de) 1998-06-02 1999-12-09 Bayer Ag Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon
AU766542B2 (en) 1998-10-08 2003-10-16 New Ace Research Company Novel compositions and methods for prevention and treatment of protozoal disease
WO2001026660A1 (en) 1999-10-08 2001-04-19 New Ace Research Company Novel compositions and methods for prevention and treatment of protozoal disease
DE10040174A1 (de) * 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen
DE10111053A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Wirkstoffkombinationen aus alpha-Liponsäure und Biochinonen
DE10356869A1 (de) * 2003-12-03 2005-07-07 Beiersdorf Ag Tensidhaltige Zubereitung mit Licochalcon A
EP1720573A4 (en) * 2004-02-27 2008-04-02 Centocor Inc METHODS AND COMPOSITIONS FOR TREATING PATHOLOGIES ASSOCIATED WITH IL-13
NZ556186A (en) 2004-12-01 2010-06-25 Acushot Inc Needle-free injector
WO2007062266A2 (en) * 2005-11-28 2007-05-31 Marinus Pharmaceuticals Ganaxolone formulations and methods for the making and use thereof
EP2020063A1 (en) * 2006-05-24 2009-02-04 Universität Hannover Laser device comprising a diffraction grating and coupled laser resonators
US8123718B2 (en) 2006-06-07 2012-02-28 Acushot Inc. Charging mechanism for a needle free injector
DE102006038292A1 (de) * 2006-08-16 2008-02-21 Bayer Healthcare Ag Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen
KR20080035374A (ko) * 2006-10-19 2008-04-23 주식회사 엘지생명과학 약제학적으로 안정한 메게스트롤 물질의 현탁액제
DE102007025908A1 (de) * 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
FR2917381B1 (fr) 2007-06-15 2009-10-16 Ceva Sante Animale Sa Conditionnement plastique multicouche pour la conservation d'une composition pharmaceutique
TW201006515A (en) 2008-03-07 2010-02-16 Pharmajet Inc Intradermal injector and uses thereof
SI22751A (sl) 2008-04-03 2009-10-31 Krka, D.D., Novo Mesto Toltrazuril z izboljĺ animi lastnostmi za raztapljanje
CN102316856A (zh) * 2009-02-27 2012-01-11 韩兀生物制药株式会社 药物制剂
CN101904858A (zh) * 2009-06-04 2010-12-08 天津瑞普生物技术股份有限公司 一种抗球虫混悬剂的制备方法
US7655597B1 (en) * 2009-08-03 2010-02-02 Specialty Fertilizer Products, Llc Pesticide compositions including polymeric adjuvants
CN102000100A (zh) * 2009-09-01 2011-04-06 天津瑞普生物技术股份有限公司 一种抗球虫的纳米混悬剂及其配制方法
CN102144975B (zh) * 2010-12-24 2012-12-12 山东省医药工业研究所 头孢丙烯混悬药物组合物
CN102743334A (zh) * 2012-07-30 2012-10-24 郑州后羿制药有限公司 一种妥曲珠利注射剂及其制备方法
EP2740492A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Triazine formulations with a second active ingredient and surfactant(s)
EP2740470A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Treatment of Coccidiosis with intramuscular triazine composition
EP2740469A1 (en) * 2012-12-07 2014-06-11 Ceva Sante Animale New treatments with triazines

Also Published As

Publication number Publication date
US20220023305A1 (en) 2022-01-27
SI2928498T1 (sl) 2022-05-31
HUE057711T2 (hu) 2022-05-28
BR112015013179B1 (pt) 2021-10-26
US20220265665A1 (en) 2022-08-25
HRP20220341T1 (hr) 2022-05-13
EP2740492A1 (en) 2014-06-11
FI4082524T3 (fi) 2025-05-23
CN111494387A (zh) 2020-08-07
BR112015013179A2 (pt) 2017-07-11
US11903947B2 (en) 2024-02-20
SI4082524T1 (sl) 2025-07-31
CN110201175A (zh) 2019-09-06
HUE071706T2 (hu) 2025-09-28
JP6363092B2 (ja) 2018-07-25
JP2018138569A (ja) 2018-09-06
EP2928498B1 (en) 2021-11-10
PH12015501219A1 (en) 2015-08-17
PL4082524T3 (pl) 2025-06-23
KR102242359B1 (ko) 2021-04-20
EP4082524B1 (en) 2025-02-26
EP4082524A1 (en) 2022-11-02
PH12015501219B1 (en) 2015-08-17
JP2016505558A (ja) 2016-02-25
US11331321B2 (en) 2022-05-17
EP2928498A1 (en) 2015-10-14
US11903946B2 (en) 2024-02-20
DK4082524T3 (da) 2025-05-26
WO2014086960A1 (en) 2014-06-12
US11911391B2 (en) 2024-02-27
UA115460C2 (uk) 2017-11-10
CA2892888A1 (en) 2014-06-12
US20150313940A1 (en) 2015-11-05
AU2013353984A1 (en) 2015-06-11
US20220023304A1 (en) 2022-01-27
PT2928498T (pt) 2022-03-08
AU2013353984B2 (en) 2017-12-21
CL2015001565A1 (es) 2015-10-23
RU2652136C2 (ru) 2018-04-25
ES3030283T3 (en) 2025-06-27
RU2015127020A (ru) 2017-01-13
KR20150107734A (ko) 2015-09-23
PT4082524T (pt) 2025-05-29
MX374912B (es) 2025-03-06
CN105007944A (zh) 2015-10-28
HRP20250623T1 (hr) 2025-07-18
CA2892888C (en) 2019-03-12

Similar Documents

Publication Publication Date Title
MX2015007130A (es) Formulaciones de triazina con un segundo principio activo y tensioactivo(s).
MX339059B (es) Composiciones para el cuidado personal.
PT2755473T (pt) Composições parasiticidas compreendendo um agente ativo de isoxazolina, métodos e suas utilizações
IN2014DN09935A (es)
MX362369B (es) Composiciones que comprenden un aroma de perfume eficiente.
MX339402B (es) Composiciones y metodos que comprenden variantes de serina proteasa.
PH12015502812A1 (en) Preserving personal care composition
FR3012962B1 (fr) Composition moussante comprenant au moins un tensioactif de type glycinate
MX2015007295A (es) Estructuracion mejorada con agentes estructurantes que contienen hidroxilo, no polimericos, cortos.
CL2017001964A1 (es) Encapsulado de agentes activos de alta potencia.
PH12015502014A1 (en) Racecadotril lipid compositions
AR091739A1 (es) Composiciones y metodos para reducir el riesgo cardiometabolico
MX2018005796A (es) Reduccion de la sensacion de picazon en la piel.
NZ702934A (en) Racecadotril lipid compositions
BR112015028824A2 (pt) composição de tensoativo concentrada
BR112015027824A8 (pt) formulação de vitamina e na forma de pó
MX2015006986A (es) Solucion de trombina y metodos de uso de esta.
MY162688A (en) Oral care compositions
MX2016003543A (es) Estructuras fibrosas mejoradas que contienen surfactantes y metodos para fabricarlas.
MX380575B (es) Composición de limpieza con una mejor eliminación de la suciedad.
HK1201189A1 (en) Use of amphoteric surfactants for the prevention and treatment of pathogenic vaginal biofilms in vaginal infections
MX365973B (es) Barras de limpieza con taurina.
AR096862A1 (es) Composición detergente
EP2978434A4 (en) COMPOSITIONS, FORMULATIONS AND METHODS FOR BIO-BALANCING THE PH OF ISOTONIC SALT SOLUTION AND STERILE HYPERTONIC SOLUTES
FR2993776B1 (fr) Agent actif et compositions cosmetiques anti-rides.

Legal Events

Date Code Title Description
FG Grant or registration